Results 21 to 30 of about 9,511 (212)

Late-Onset Neuromyelitis Optica Spectrum Disorder Mimicking a Non-Arteritic Anterior Ischemic Optic Neuropathy–Case Report [PDF]

open access: yes, 2023
A 60-year-old white woman presented to the emergency department with painless decrease of visual acuity in the left eye (LE). The diagnosis of a non-arteritic anterior ischemic optic neuropathy in the LE was established based on the clinical picture and ...
Lech Sedlak   +2 more
core   +1 more source

Magnetic resonance imaging in neuromyelitis optica spectrum disorder [PDF]

open access: yes, 2021
Neuromyelitis optica spectrum disorder (NMOSD) is an inflammatory disease of the central nervous system (CNS) associated with antibodies to aquaporin‐4 (AQP4), which has distinct clinical, radiological and pathological features, but also has some overlap
Arnett, Simon   +5 more
core   +1 more source

Neuromyelitis Optica Spectrum Disorder Complicated by Posterior Reversible Encephalopathy Syndrome as an Initial Manifestation [PDF]

open access: yes, 2020
A 25-year-old woman was admitted to our hospital due to tonic convulsion with severe headache after having experienced symptoms of nausea and vomiting for a month.
Tateishi, Yohei   +12 more
core   +1 more source

Neuromyelitis Optica Spectrum Disorder

open access: yesCureus, 2023
Neuromyelitis optica spectrum disorder (NMOSD) is an autoimmune condition characterized by recurrent episodes of optic neuritis (ON) and transverse myelitis. This case report aims to highlight the importance of considering atypical presentations of NMOSD when confronted with MRI-detected Wernicke's encephalopathy.
Cazzaniga, Juliana   +5 more
openaire   +2 more sources

Relapsing neuromyelitis optica spectrum disorder

open access: yesJournal of Dr. NTR University of Health Sciences, 2021
Background: Neuromyelitis optica spectrum disorder (NMOSD) is a devastating inflammatory disorder of the central nervous system. Relapsing NMOSD (RNMOSD) is being reported frequently, leading to severe and permanent relapse related disability.
M Lakshmi Lavanya   +4 more
doaj   +1 more source

The efficacy of rituximab in the therapy of neuromyelitis optica in a patient with Sjogren's syndrome: case-report and literature review [PDF]

open access: yesТерапевтический архив, 2018
This case is the first description of the successful anti-B-cell therapy with rituximab in a patient with Sjogrenʼs syndrome and neuromyelitis optica spectrum disorder in Russia.
A V Torgashina, V I Vasilyev
doaj   +1 more source

Update on neuromyelitis optica spectrum disorder [PDF]

open access: yesCurrent Opinion in Ophthalmology, 2020
Purpose of reviewNeuromyelitis optica spectrum disorder is an autoimmune disease that causes optic neuritis and transverse myelitis. Attacks can cause severe neurological damage leading to blindness and paralysis. Understanding of the immunopathogenesis of this disease has led to major breakthroughs in diagnosis and treatment.
Kathryn B, Holroyd   +2 more
openaire   +2 more sources

Fahr’s syndrome as a manifestation of autoimmune polyendocrine syndrome-1 and its unusual association with neuromyelitis optica spectrum disorder

open access: yesFrontiers in Neuroscience, 2023
Fahr’s syndrome, also known as bilateral striopallidodendate calcinosis, is a rare inherited neurodegenerative illness characterized by abnormal calcium deposition in several areas of the brain, resulting in a wide range of neuropsychological symptoms ...
Ahmad Nawaz   +5 more
doaj   +1 more source

Treatment of neuromyelitis optica/neuromyelitis optica spectrum disorders with methotrexate [PDF]

open access: yesBMC Neurology, 2014
To review our experience using methotrexate as a single long-term immunosuppressant (IS) therapy in neuromyelitis optica/neuromyelitis optica spectrum disorders (NMO/NMOSD).We performed a retrospective chart review of all patients with a diagnosis of NMO/NMOSD, supported by a positive NMO-IgG testing, who were treated with methotrexate. A paired sample
Ramanathan, Ramnath Santosh   +2 more
openaire   +2 more sources

Treating multiple sclerosis and neuromyelitis optica spectrum disorder during the COVID-19 pandemic [PDF]

open access: yes, 2020
The emergence of novel Coronavirus 2019 (COVID-19)1 and the subsequent pandemic present a unique challenge to Neurologists managing patients with multiple sclerosis (MS) and related neuroinflammatory disorders, such as neuromyelitis spectrum disorder ...
Killestein, J   +9 more
core   +1 more source

Home - About - Disclaimer - Privacy